Several genetic variants may affect its activity, with some associated with Dubin–Johnson syndrome [74] or the susceptibility to develop diclofenac-induced hepatotoxicity, such as the ABCC2 rs717620 polymorphism [75]. This evidence concerns the gene ABCC2 and Dubin-Johnson syndrome.